Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Dow
Daiichi Sankyo
Merck
Harvard Business School
Cipla
Argus Health
Chinese Patent Office
Accenture

Generated: August 17, 2018

DrugPatentWatch Database Preview

Actavis Labs Fl Company Profile

« Back to Dashboard

What is the competitive landscape for ACTAVIS LABS FL, and what generic and branded alternatives to ACTAVIS LABS FL drugs are available?

ACTAVIS LABS FL has seventy-seven approved drugs.

There are two tentative approvals on ACTAVIS LABS FL drugs.

Summary for Actavis Labs Fl
US Patents:0
Tradenames:61
Ingredients:59
NDAs:77

Drugs and US Patents for Actavis Labs Fl

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Fl Inc CABERGOLINE cabergoline TABLET;ORAL 078035-001 Apr 21, 2008 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Actavis Labs Fl Inc QUINAPRIL HYDROCHLORIDE quinapril hydrochloride TABLET;ORAL 076049-002 Jan 14, 2005 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Actavis Labs Fl Inc GLIMEPIRIDE glimepiride TABLET;ORAL 076995-003 Apr 27, 2010 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Actavis Labs Fl GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE guaifenesin; pseudoephedrine hydrochloride TABLET, EXTENDED RELEASE;ORAL 091071-002 May 27, 2015 OTC No No ➤ Try a Free Trial ➤ Try a Free Trial
Actavis Labs Fl Inc HYDROCODONE BITARTRATE AND ACETAMINOPHEN acetaminophen; hydrocodone bitartrate TABLET;ORAL 206470-001 Jun 2, 2016 AA RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Actavis Labs Fl Inc FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE fosinopril sodium; hydrochlorothiazide TABLET;ORAL 076608-002 Dec 3, 2004 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for ACTAVIS LABS FL drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
McKinsey
Express Scripts
Teva
Julphar
US Department of Justice
Queensland Health
US Army
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.